Press Release: Late-breaking amlitelimab Phase 2b data presented at EADV show potential best-in-class profile in atopic dermatitis

Nitesh sinha October 13, 2023
https://ift.tt/4izlXwW

from Sanofi - Aventis Groupe https://ift.tt/5Ve82K7
via IFTTT
Tags:
Nitesh sinha

Posted by: Nitesh sinha

Post a Comment

0 Comments

Please ,
Do not enter any kind of span link